The paediatric population: the forgotten element to eliminating hepatitis C virus

Lancet Gastroenterol Hepatol. 2020 Apr;5(4):334-335. doi: 10.1016/S2468-1253(19)30405-4. Epub 2020 Jan 16.
No abstract available

MeSH terms

  • Adolescent
  • Antiviral Agents / administration & dosage
  • Antiviral Agents / therapeutic use
  • Benzimidazoles / administration & dosage
  • Benzimidazoles / therapeutic use
  • Child
  • Chronic Disease
  • Drug Therapy, Combination
  • Female
  • Fluorenes / administration & dosage
  • Fluorenes / therapeutic use
  • Hepacivirus / drug effects
  • Hepacivirus / isolation & purification*
  • Hepatitis C / complications*
  • Hepatitis C / epidemiology
  • Hepatitis C / mortality
  • Hepatitis C / transmission
  • Humans
  • Infectious Disease Transmission, Vertical / prevention & control*
  • Infectious Disease Transmission, Vertical / statistics & numerical data
  • Liver Diseases / etiology*
  • Male
  • Prevalence
  • Risk Factors
  • Sofosbuvir
  • Uridine Monophosphate / administration & dosage
  • Uridine Monophosphate / analogs & derivatives
  • Uridine Monophosphate / therapeutic use
  • Young Adult

Substances

  • Antiviral Agents
  • Benzimidazoles
  • Fluorenes
  • ledipasvir, sofosbuvir drug combination
  • Uridine Monophosphate
  • Sofosbuvir